Locust Wood Capital Advisers, LLC Gsk PLC Transaction History

Locust Wood Capital Advisers, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 01, 2019	SELL	$37.8 - $42.69 $26.3 Million - $29.7 Million	-696,765 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$39.75 - $42.69 $154,230 - $165,637	3,880 Added 0.56%	696,765 $28 Million
Q2 2018 Aug 09, 2018	BUY	$39.61 - $42.76 $1.22 Million - $1.32 Million	30,755 Added 4.64%	692,885 $27.9 Million
Q1 2018 Apr 18, 2018	BUY	$36.18 - $40.15 $24 Million - $26.6 Million	662,130 New	662,130 $25.9 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.6B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Locust Wood Capital Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Locust Wood Capital Advisers, LLC with notifications on news.